Warrior CARE: Cannabis Behavioral Health

Launched by WAYNE STATE UNIVERSITY · Apr 18, 2024

Keywords

ClinConnect Summary

The Warrior CARE trial is a research study that aims to explore how cannabis, or marijuana, might help veterans who are struggling with Post Traumatic Stress Disorder (PTSD) and thoughts of suicide. This study will involve veterans who have used cannabis before and meet certain criteria, like having served in the military and experiencing PTSD symptoms for at least six months. It’s important to note that the study is currently not recruiting participants and will focus on veterans aged 18 and older.

To be eligible for the trial, participants need to be able to understand and give consent to be part of the study, have a certain level of intelligence, and have used cannabis no more than twice in the past month. They should not have any serious medical issues or a history of severe mental health problems. Participants can expect to be part of a controlled study, which means they will be randomly assigned to receive either cannabis or a placebo (a non-active substance) and monitored throughout the trial. This research is important as it could help improve treatment options for veterans facing these difficult challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • able to provide informed consent, IQ Score \>80,
• • served in branch of the US armed forces, report using cannabis,
• • report using cannabis (no more than 2x in last month and no more than 100 lifetime use episodes)
• • meet DSM-5 criteria for PTSD w/ Sx of at least 6 months duration
• Exclusion Criteria:
• • urine drug screen positive for any other drugs
• • systolic/diastolic BP \>140/90 mmHg?
• • any clinically significant medical problems,
• • any current or past serious psychotic or bipolar disorder diagnosis as determined by SCID-5
• • at immediate high risk for suicide based on the C-SSRS
• • current SUD other than Nicotine Use Disorder and Alcohol Use Disorder (mild or moderate)
• • pregnancy, lactating
• • unable to provide informed consent